Ambra Spolverini
Impact in
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hemoglobinopathies and Related Disorders
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
- Genetics 8
- Myeloproliferative Neoplasms: Diagnosis and Treatment 8
-
- Chronic Myeloid Leukemia Treatments 5
- Acute Myeloid Leukemia Research 3
- Co-authors
- Alessandro Maria Vannucchi (6 shared papers)Lisa Pieri (4 shared papers)Alberto Bosi (3 shared papers)Gilad Fuchs (1 shared paper)Débora Rosa Bublik (1 shared paper)Moshe Oren (1 shared paper)Paola Guglielmelli (3 shared papers)Alessandro Pancrazzi (2 shared papers)
- Journals
- Leukemia Research (2 papers)Leukemia (2 papers)Blood (2 papers)Haematologica (1 paper)Oncogene (1 paper)
- Partner nations
- ItalyUnited KingdomSpain
In The Last Decade
Ambra Spolverini
10 papers receiving 761 citations
Ambra Spolverini's Hit Papers
Peers
Comparison fields: 5 of 33
- Genetics 673
- Hematology 529
- Rheumatology 243
- Molecular Biology 378
- Cancer Research 29
Countries citing papers authored by Ambra Spolverini
This map shows the geographic impact of Ambra Spolverini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ambra Spolverini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ambra Spolverini more than expected).
Fields of papers citing papers by Ambra Spolverini
This network shows the impact of papers produced by Ambra Spolverini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ambra Spolverini. The network helps show where Ambra Spolverini may publish in the future.
Co-authors
The 25 scholars most cited alongside Ambra Spolverini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mutations and prognosis in primary myelofibrosis Hit paper breakdown → | 2013 | 636 |
| 2 | 2011 | 35 | |
| 3 | 2017 | 26 | |
| 4 | 2013 | 26 | |
| 5 | 2010 | 23 | |
| 6 | 2011 | 14 | |
| 7 | 2010 | 5 | |
| 8 | 2013 | 3 | |
| 9 | 2012 | 1 | |
| 10 | JAK2 46/1ハプロタイプは内臓静脈血栓症関連性BCR-ABL陰性の典型的骨髄増殖性腫瘍の素因となる | 2012 | 1 |
About Ambra Spolverini
Ambra Spolverini is a scholar working on Genetics, Hematology, Rheumatology, Molecular Biology and Cancer Research, having authored 10 papers that have together received 770 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Chronic Myeloid Leukemia Treatments (5 papers), Eosinophilic Disorders and Syndromes (4 papers), Acute Myeloid Leukemia Research (3 papers), Kruppel-like factors research (3 papers), RNA modifications and cancer (1 paper), Cancer-related molecular mechanisms research (1 paper) and Cytokine Signaling Pathways and Interactions (1 paper). The work is most often cited by research in Genetics (673 citations), Hematology (529 citations), Rheumatology (243 citations), Molecular Biology (378 citations) and Cancer Research (29 citations). Ambra Spolverini has collaborated with scholars based in Italy, United Kingdom and Spain. Frequent co-authors include Alessandro Maria Vannucchi, Lisa Pieri, Alberto Bosi, Gilad Fuchs, Débora Rosa Bublik, Moshe Oren, Paola Guglielmelli, Alessandro Pancrazzi, Barbara Scappini and Francesco Albano. Their work appears in journals such as Leukemia Research, Leukemia, Blood, Haematologica and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.